IRS2 and breast carcinoma: A recent study identified a unique region within the IRS-2 C-terminal tail that is necessary and sufficient for breast cancer cell invasion, but is not required for IRS-2 dependent regulation of glucose uptake [124], suggesting that the role(s) that IRS-2 plays in breast cancer progression can be separated from its role in glucose metabolism.